Ledger.Open graph →

SEC Form D · Amendment · filed December 12, 2016

PROFECTUS BIOSCIENCES, INC

Offering

$4.0M

Sold

$300K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BALTIMORE, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Thomas G. Pease · Baltimore, MDExec · Director Thomas A. Lynch · Baltimore, MDDirector William K. Haseltine · Baltimore, MDDirector Jeffrey N. Meshulam · Baltimore, MDExec · Director M.G. A. Sarngadharan · Baltimore, MDDirector Michael K. Greenebaum · Baltimore, MDDirector Frederick C. Tecce · Baltimore, MDDirector Brian K. Adamsky · Baltimore, MDDirector Terry A. Lierman · Baltimore, MDDirector Lawrence V. Kohn · New York, NYDirector John Boylan · Houston, TXDirector David J. Neithercut · Chicago, ILDirector Mark J. Parrell · Chicago, ILDirector Stephen L. Hartzell · Houston, TXDirector Kane Street Fund GP LLC · New York, NYExec · Director M. C. Gibbons · Ann Arbor, MIDirector Kane Street Capital Management LLC · New York, NYExec · Director Carrie Milsap · Redding, CADirector Orrie L. Tawes · Houston, TXDirector R. K. Grimes · Houston, TXExec · Director Roy K. Jageman · Houston, TXExec · Director Cyrille Habis · Mountain View, CADirector Andrew J. Solimine · San Francisco, CADirector Peter Anderson · Redding, CADirector Colette Boudreau · Redding, CADirector Bill Davis · Redding, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗